Australian medical device company Oventus Medical Ltd. (ASX:OVN), has lodged an FDA 510k submission for its O2Vent W device - an oral appliance intended to reduce or alleviate snoring, mild to moderate obstructive sleep apnoea and severe sleep apnoea when the patient is intolerant to Continuous Positive Airway Pressure Devices.
Sleep disorder device manufacturer and developer Oventus Medical Ltd. (ASX:OVN) is pleased to announce significant progress has been made regarding the clinical validation of the Oventus O2Vent oral appliances and, in particular, validation of the benefit of the Oventus proprietary airway.
Algae.Tec Limited (ASX:AEB) (OTCMKTS:ALGXY) is pleased to announce that it has entered into a Collaboration and Licence Term Sheet with Jardin De Invierno SA to expand its technology and product footprint into the rapidly growing medicinal marijuana and associated markets.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that Harvest One Cannabis Inc. (CVE:HVST) through its wholly-owned subsidiaries United Greeneries Ltd. and United Greeneries Saskatechwan Ltd., has entered into two separate agreements with PanCann Streaming Corp. to finance the construction of both the Lucky Lake facility and a new additional production facility to be identified.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 31 March 2017.
Sleep disorder device manufacturer and developer Oventus Medical Ltd. (ASX:OVN) is pleased to announce significant clinical progress made with the Oventus O2Vent oral appliance with a Positive Airway connection.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Harvest One Capital Inc. (CVE:WON.H) has announced the closure of the acquisition of MMJ's wholly-owned subsidiaries United Greeneries Holdings Ltd and Satipharm AG.
